SCVIi014-A

Registration Summary:

A P E C

The cell line is not submitted yet.

(only basic data is shown)

General

Cell Line
hPSCreg name	SCVIi014-A
Cite as:	SCVIi014-A (RRID:CVCL_A9AI)
Cell line type	Human induced pluripotent stem cell (hiPSC)
Similar lines	No similar lines found.
Last update	2nd June 2021
User feedback	Written by on No feedback available yet. Login to share your feedback, experiences or results with the research community.
Provider
Generator	Stanford Cardiovascular Institute (SCVI) Contact: Stanford Cardiovascular Institute (SCVI)
External Databases
BioSamples	SAMEA9082265
Cellosaurus	CVCL_A9AI
Wikidata	Q108821279
General Information
Publications	Zhang H et al. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene. Stem cell research. 2021 Aug;55:102492. Zhang Hao et al. Multiscale drug screening for cardiac fibrosis identifies MD2 as a therapeutic target. Cell. 2024-12-00.
* Is the cell line readily obtainable for third parties?	Yes Research use: allowed Clinical use: not allowed Commercial use: not allowed

hIPSC Derivation

General
Source cell line name	PBMC-34 Derived from same source line (potentially other lot and donor, see below): PUMCHi001-A UKBi016-A UKBi020-A UKBi021-A